1,626
Views
4
CrossRef citations to date
0
Altmetric
Public Health & Policy

Driving more WHO-recommended vaccines in the National Immunization Program: Issues and challenges in China

, , , , , ORCID Icon & show all
Article: 2194190 | Received 09 Jan 2023, Accepted 19 Mar 2023, Published online: 26 Apr 2023

References

  • World Health Assembly (27th: 1974). The expanded programme on immunization: the 1974 resolution by the world health assembly. Assignment Child. 1985;69-72:87–8. PMID: 12280461.
  • The National People’s Congress of the People’s Republic of China. Vaccine administration law of the People’s Republic of China. [accessed 2022 Apr 22]. http://www.npc.gov.cn/npc/c30834/201907/11447c85e05840b9b12c62b5b645fe9d.shtml. (in Chinese).
  • Japan Health Policy Now. Routine and voluntary immunization. [accessed 2022 May 25]. https://japanhpn.org/en/vaccinations-2/.
  • Lang S, Loving S, McCarthy ND, Ramsay ME, Salisbury D, Pollard AJ. Two centuries of immunisation in the UK (part II). Arch Dis Child. 2020;105(3):216–22. doi:10.1136/archdischild-2019-317707. PMID: 31302603.
  • GOV.UK. Historical vaccine development and introduction of vaccines in the UK. [accessed 2022 May 25]. https://www.gov.uk/government/publications/vaccination-timeline.
  • Huang L, Li ZJ, Wang FS, Gao F. Achievements and prospect in prevention and treatment of infectious diseases during the last 70 years in China. Chinese J Gen Pract. 2019;17(10):1615–18. (in Chinese). doi:10.16766/j.cnki.issn.1674-4152.001011.
  • Yang WZ. Dramatic achievements in infectious disease prevention and treatment in China during the past 70 years. Chin J Epidemiol. 2019;12:1493–4. (in Chinese). doi:10.3760/cma.j.issn.0254-6450.2019.12.001.
  • Pan JH, Wang YS, Cao LS, Wang Y, Zhao Q, Tang SL, Gong WF, Guo L, Liu ZX, Wen ZX, et al. Impact of immunization programs on 11 childhood vaccine-preventable diseases in China: 1950-2018. Innovation (Camb). 2021;2(2):100113. doi:10.1016/j.xinn.2021.100113. PMID: 34557762.
  • Ministry of Health of the People’s Republic of China. Report of the survey of the third 85% vaccination coverage target of the national expanded programme on immunizations. [accessed 2022 Apr 22]. http://www.gov.cn/gzdt/content_1295858.htm. (in Chinese).
  • Yu W, Lee LA, Liu Y, Scherpbier RW, Wen N, Zhang G, Zhu X, Ning G, Wang F, Li Y, et al. Vaccine-preventable disease control in the People’s Republic of China: 1949-2016. Vaccine. 2018;36(52):8131–7. doi:10.1016/j.vaccine.2018.10.005. PMID: 30497834.
  • State Council of the People’s Republic of China. Healthy China 2030 planning outline. [accessed 2022 Apr 8]. http://www.gov.cn/zhengce/2016-10/25/content_5124174.htm.
  • National Health Commission of the People‘s Republic of China. Statutes of the National Advisory Committees on Immunization. Chinese J Vaccines Immun. 2018;24(5):608–9. (in Chinese).
  • The Standing Committee of the National People’s Congress of the People’s Republic of China. Vaccine administration law of the People’s Republic of China. [accessed 2022 Mar 9]. http://www.npc.gov.cn/npc/c30834/201907/11447c85e05840b9b12c62b5b645fe9d.shtml/. (in Chinese).
  • World Health Organization. Immunization data - vaccine schedule. [accessed 2022 Mar 9]. https://immunizationdata.who.int/pages/schedule-by-country.
  • Chinese National Bureau of Statistics. Notifiable infectious disease. [accessed 2022 Apr 8]. http://www.stats.gov.cn/tjsj/. (in Chinese).
  • World Health Organization. Immunization Agenda 2030: a global strategy to leave no one behind. [accessed 2022 Apr 25]. https://www.who.int/publications/m/item/immunization-agenda-2030-a-global-strategy-to-leave-no-one-behind.
  • World Health Organization. WHO recommendations for routine immunization. [accessed 2022 Apr 8]. https://www.who.int/teams/immunization-vaccines-and-biologicals/policies/who-recommendations-for-routine-immunization—summary-tables.
  • Lai XZ, Rong HG, Ma XC, Hou ZY, Li SP, Jing RZ, Zhang HJ, Peng ZB, Feng LZ, Fang H. Willingness to pay for seasonal influenza vaccination among children, chronic disease patients, and the elderly in China: a national cross-sectional survey. Vaccines (Basel). 2020;8(3):405. doi:10.3390/vaccines8030405. PMID: 32707831.
  • Beijing Municipal Commission of Health. Vaccination procedures and instructions of Beijing immunization program (2021 Edition). [accessed 11 Apr 2022]. http://wjw.beijing.gov.cn/zwgk_20040/zxgk/202106/t20210601_2403042.html.
  • Lai XZ, Wahl B, Yu WZ, Xu TT, Zhang HJ, Garcia C, Qin Y, Guo Y, Yin ZD, Knoll MD, et al. National, regional, and provincial disease burden attributed to Streptococcus pneumoniae and Haemophilus influenzae type b in children in China: modelled estimates for 2010-17. Lancet Reg Health West Pac. 2022;22:100430. doi:10.1016/j.lanwpc.2022.100430. PMID: 35308577.
  • Wang YH, Cheng MN, Wang SY, Wu F, Yan QH, Yang QQ, Li YY, Guo X, Fu C, Shi Y, et al. Vaccination coverage with the pneumococcal and influenza vaccine among persons with chronic diseases in Shanghai, China, 2017. BMC Public Health. 2020;20(1):359. doi:10.1186/s12889-020-8388-3. PMID: 32188428.
  • Shanghai Municipal Commission of Health. Vaccination procedures of Shanghai immunization program (2018 Edition). [accessed 2022 Apr 11]. http://wsjkw.sh.gov.cn/mygh-gjhbsmyghym/20191012/0012-65379.html.
  • Zou Z, Fairley CK, Ong JJ, Hocking J, Canfell K, Ma X, Chow EPF, Xu XL, Zhang L, Zhuang GH. Domestic HPV vaccine price and economic returns for cervical cancer prevention in China: a cost-effectiveness analysis. Lancet Glob Health. 2020;8(10):e1335–44. doi:10.1016/S2214-109X(20)30277-1. PMID: 32971056.
  • Zhou LR, Wang J, Cheng PX, Li Y, Liu GX, Zhang X. HPV vaccine hesitancy among medical students in China: a multicenter survey. Front Public Health. 2022;10:774767. doi:10.3389/fpubh.2022.774767. PMID: 35265570.
  • Suo LD, Lu L, Zhao D, Pang XH. Impact of a 2-dose voluntary vaccination strategy on varicella epidemiology in Beijing, 2011-2017. Vaccine. 2020;38(20):3690–6. doi:10.1016/j.vaccine.2020.01.087. PMID: 32204940.
  • He YN, Liu Y, Dai BB, Zhao L, Lin JQ, Yang J, Yu HJ. Assessing vaccination coverage, timeliness, and its temporal variations among children in a rural area in China. Hum Vaccin Immunother. 2021;17(2):592–600. doi:10.1080/21645515.2020.1772620. Epub 2020 Jul 9. PMID: 32643509.
  • Handbook-Germany. Vaccination Schedule in Germany. [accessed 2022 Mar 10]. https://handbookgermany.de/en/live/vaccination.
  • United States Centers for Disease Control and Prevention. Recommended child and adolescent immunization schedule for ages 18 years or younger, United States, 2022. [accessed 2022 Mar 10]. https://www.cdc.gov/vaccines/schedules/hcp/imz/child-adolescent.html.
  • Australian Government Department of Health. Australian Immunisation Handbook. [accessed 2022 Apr 8]. https://immunisationhandbook.health.gov.au/.
  • Lu PJ, Hung MC, Srivastav A, Grohskopf LA, Kobayashi M, Harris AM, Dooling KL, Markowitz LE, Rodriguez-Lainz A, Williams WW. Surveillance of vaccination coverage among adult populations -United States, 2018. MMWR Surveill Summ. 2021;70(3):1–26. doi:10.15585/mmwr.ss7003a1. PMID: 33983910.
  • Moran A, Agaliotis M, Seale H. The views of key stakeholders around mandatory influenza vaccination of hospital and aged care staff: examining the current climate in Australia. Vaccine. 2019;37(5):705–10. doi:10.1016/j.vaccine.2018.12.029. PMID: 30626529.
  • Van Buynder PG, Konrad S, Kersteins F, Preston E, Brown PD, Keen D, Murray NJ. Healthcare worker influenza immunization vaccinate or mask policy: strategies for cost effective implementation and subsequent reductions in staff absenteeism due to illness. Vaccine. 2015;33(13):1625–8. doi:10.1016/j.vaccine.2015.01.048. PMID: 25678243.
  • Liu HT, Tan YY, Zhang ML, Peng ZB, Zheng JD, Qin Y, Guo ZQ, Yao JH, Pang F, Ma T, et al. An internet-based survey of influenza vaccination coverage in healthcare Workers in China, 2018/2019 season. Vaccines (Basel). 2019;8(1):6. doi:10.3390/vaccines8010006. PMID: 31887994.
  • Yi HY, Yang Y, Zhang L, Zhang ML, Wang Q, Zhang T, Zhang YY, Qin Y, Peng ZB, Leng ZW, et al. Improved influenza vaccination coverage among health-care workers: evidence from a web-based survey in China, 2019/2020 season. Hum Vaccin Immunother. 2021;17(7):2185–9. doi:10.1080/21645515.2020.1859317. PMID: 33497309.
  • Saitoh A, Okabe N. Changes and remaining challenges for the Japanese immunization program: closing the vaccine gap. Vaccine. 2021;39(22):3018–24. doi:10.1016/j.vaccine.2021.04.023. PMID: 33931250.
  • The United States Department of Health & Human Services. How to pay. [accessed 2022 Apr 19]. https://www.vaccines.gov/getting/pay.
  • Sussex J, Shah K. The publicly funded vaccines market in the UK. London: Office of Health Economics; 2010.
  • Zheng YM, Rodewald L, Yang J, Qin Y, Pang MF, Feng LZ, Yu HJ. The landscape of vaccines in China: history, classification, supply, and price. BMC Infect Dis. 2018;18(1):502. doi:10.1186/s12879-018-3422-0. PMID: 30286735.
  • Hu Y, Luo SY, Tang XW, Lou LQ, Chen YP, Guo J. Comparative assessment of immunization coverage of migrant children between national immunization program vaccines and non-national immunization program vaccines in East China. Hum Vaccin Immunother. 2015;11(3):761–8. doi:10.1080/21645515.2015.1012015. PMID: 25760670.
  • Wagner AL, Sun X, Montgomery JP, Huang Z, Boulton ML. The impact of residency and urbanicity on Haemophilus influenzae type b and pneumococcal immunization in Shanghai children: a retrospective cohort study. Plos One. 2014;9(5):e97800. doi:10.1371/journal.pone.0097800. PMID: 24828814.
  • Zhuang JL, Wagner AL, Laffoon M, Lu YH, Jiang QW. Procurement of category 2 vaccines in China. Vaccines (Basel). 2019;7(3):97. doi:10.3390/vaccines7030097. PMID: 31450855.
  • Li XH, Li MY, Fu CW, Yan F, Wang N, Wang W, Kezhong A, Wang Y. Current situation and challenges of vaccine supply management in China. Chinese Health Resources. 2021;24(02):150–2. doi:10.13688/j.cnki.chr.2021.200314. (in Chinese).
  • United Nations International Children’s Emergency Fund (UNICEF). Guidelines to complete the 2011-2015 immunization forecast spreadsheet. [accessed 2022 Mar 22]. http://www.unicef.org/supply/files/Instructions_for_Immunization_Forecast_Tool_2011_-_English.doc.
  • Shrestha SS, Wallace GS, Meltzer MI. Modeling the national pediatric vaccine stockpile: supply shortages, health impacts and cost consequences. Vaccine. 2010;28(38):6318–32. doi:10.1016/j.vaccine.2010.06.095. PMID: 20638451.
  • World Health Organization. Vaccine forecasting. [accessed 2022 Mar 22]. http://www.who.int/immunization_delivery/systems_policy/logistics_annual_needs/en/index.html.
  • Lin SQ, Liu TC, Wang JR, Qi Z, Sun KJ. Survey of vaccination clinic human resources and vaccination staff job satisfaction in Jinan city, 2017. Chinese J Vaccines Immun. 2019;25(3):326–9. doi:10.19914/j.cjvi.2019.03.021. (in Chinese).
  • Yu WZ, Ye JK, Wu J, Shi JJ, Cao L, Cao LS, Wang HQ, An ZJ, Ying ZD. Challenges and recommendations on development for the national immunization programme in China. Chinese J Vaccines Immun. 2020;26:574–7. doi:10.19914/j.cjvi.2020.05.020. (in Chinese).
  • Sun HF, Cao LS, Yu WZ, Cao L, Zhang YW, Ye JK, Song YF. Routine immunization unit and staff changes over time in China. Chinese J Vaccines Immun. 2020;26(2):193–7. doi:10.19914/j.cjvi.2020.02.016. (in Chinese).
  • Sun HF. The study on the current status and trend of primary vaccination services in China: Chinese center for disease control and prevention; 2020. (in Chinese). doi:10.27511/d.cnki.gzyyy.2020.000077.
  • The National People’s Congress of the People’s Republic of China. Vaccines administration law of the People’s Republic of China. [accessed 2022 May 25]. http://www.npc.gov.cn/englishnpc/c23934/202012/0b1fd779c29e49bd99eb0e65b66aa783.shtml. (in Chinese).
  • Wu W, Cao L, Zheng J, Cao L, Cui J, Xiao Q. Immunization information system status in China, 2017. Vaccine. 2019;37(43):6268–70. doi:10.1016/j.vaccine.2019.08.070. PMID: 31526621.
  • World Health Organization. Understanding the behavioural and social drivers of vaccine uptake WHO position paper May 2022. Wkly Epidemiol Rec. 2022;97(20):209–24. https://www.who.int/publications/i/item/who-wer9720-209-224.
  • Han Y, Wang Q, Zhao SY, Wang JL, Dong SH, Cui TT, Liu MQ, Shi NY, Yang LQ, Han Y, et al. Parental category B vaccine hesitancy and associated factors in China: an online cross-sectional survey. Expert Rev Vaccines. 2022;21(1):145–53. doi:10.1080/14760584.2022.2008247. PMID: 34792433.
  • Liu XY, Hu WJ, Zhang SB. The trust degree of parents on the Shanxi vaccination progrma affected by the Shandong vaccine crisis in 2016. J China Vaccine Immun. 2018;24(1):83–8. doi:10.19914/j.cjvi.2018.01.020. in Chinese.
  • Scales D, Gorman J, Jamieson KH. The covid-19 infodemic - applying the epidemiologic model to counter misinformation. N Engl J Med. 2021;385(8):678–81. doi:10.1056/NEJMp2103798. PMID: 33979506.
  • Wagner AL, Gordon A, Tallo VL, Simaku A, Porter RM, Edwards LJ, Duka E, Abu-Khader I, Gresh L, Sciuto C, et al. Intent to obtain pediatric influenza vaccine among mothers in four middle income countries. Vaccine. 2020;38(27):4325–35. doi: 10.1016/j.vaccine.2020.04.028. PMID: 32387013.
  • Yang R, Penders B, Horstman K. Addressing vaccine hesitancy in China: a scoping review of Chinese scholarship. Vaccines (Basel). 2019;8(1):2. doi:10.3390/vaccines8010002. PMID: 31861816.
  • Houweling H, Verweij M, Ruitenberg EJ. Criteria for inclusion of vaccinations in public programmes. Vaccine. 2010;28(17):2924–31. doi:10.1016/j.vaccine.2010.02.021. PMID: 20189486.
  • Lahariya C, Paruthi R, Bhattacharya M. How a new health intervention affects the health systems? Learnings from pentavalent vaccine introduction in India. Indian J Pediatr. 2016;83(4):294–9. doi:10.1007/s12098-015-1844-x. PMID: 26264631.
  • Gavi. Gavi’s business model. [accessed 2022 Apr 25]. https://www.gavi.org/about/gavis-business-model/.
  • Hussain R, Bukhari NI, Ur RA, Hassali MA, Babar ZU. Vaccine prices: a systematic review of literature. Vaccines (Basel). 2020;8(4):629. doi:10.3390/vaccines8040629. PMID: 33137948.
  • Jarrett C, Wilson R, O’leary M, Eckersberger E, Larson HJ, SAGE Working Group on Vaccine Hesitancy. Strategies for addressing vaccine hesitancy - a systematic review. Vaccine. 2015;33(34):4180–90. doi:10.1016/j.vaccine.2015.04.040. PMID: 25896377.
  • Centers for Disease Control and Prevention. How to address COVID-19 vaccine misinformation. [accessed 2022 May 25]. https://www.cdc.gov/vaccines/covid-19/health-departments/addressing-vaccine-misinformation.html.
  • Paterson P, Meurice F, Stanberry LR, Glismann S, Rosenthal SL, Larson HJ. Vaccine hesitancy and healthcare providers. Vaccine. 2016;34(52):6700–6. doi:10.1016/j.vaccine.2016.10.042. PMID: 27810314.